Zobrazeno 1 - 10
of 186
pro vyhledávání: '"J. Ragaz"'
Autor:
J. Ragaz, S. Shakeraneh
Publikováno v:
Current Oncology
Volume 22
Issue 3
Pages 2568-224
Volume 22
Issue 3
Pages 2568-224
Dr. Pierre Band’s book on The History of Medical Oncology from Early Days does matter—particularly nowadays, in the era of fast developments and a rising number of subspecialties with language at times too specialized to follow. From that perspec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42ff471b910751118f37046fadb4ef84
https://europepmc.org/articles/PMC4462544/
https://europepmc.org/articles/PMC4462544/
Autor:
J. Ragaz, J.J. Spinelli
Publikováno v:
International Journal of Cancer. 87:423-426
Autor:
J Ragaz
Publikováno v:
Endocrine-related cancer. :277-291
Aromatase is one of the key enzymes possibly linked with the perpetuation or even initiation of breast cancer. Modulation of its activity by the new generation inhibitors has resulted in increased responses and improved therapeutic ratio compared wit
Publikováno v:
Journal of Clinical Oncology. 16:2018-2024
PURPOSE This study provides estimates of the effect of tamoxifen treatment on mortality from four conditions known to be affected by tamoxifen in women who survive their breast cancer: contralateral breast cancer, cardiovascular events, endometrial c
Autor:
J Ragaz, J J Spinelli
Publikováno v:
Radiotherapy and Oncology. 52:203-205
Publikováno v:
Cancer Research. 72:P6-07
Objectives: The purpose of this prospective study was to determine whether baseline maximum standard uptake value (SUVmax) in metastatic breast cancer (MBC) patients correlates with validated prognostic markers and their luminal subtypes. Whether bas
Publikováno v:
European Journal of Cancer Supplements. 7:19-20
Autor:
Lynne Nakashima, S. Rielly, C. Campbell, A. Tolcher, Karen A. Gelmon, C. Bryce, D. Ayers, S. O'Reilly, J. Ragaz, T. Shenkier, H. Dulude
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 9(11)
Summary Background Single-agent bi-weekly paclitaxel was studied as first-line metastatic treatment for breast cancer in a phase I–II trial. Patients and methods Thirty-eight women with metastatic breast cancer were enrolled. Thirty-seven are evalu
Publikováno v:
Cancer. 83(5)
The increasing use of systemic therapy for women with lymph node negative breast carcinoma and earlier stage of disease at mammographic detection raises questions regarding the need for routine axillary lymph node dissection. Predictive modeling for
Autor:
J, Ragaz
Publikováno v:
Oncology (Williston Park, N.Y.). 11(2 Suppl 1)
Tamoxifen has well-documented activity in reducing breast cancer mortality. In addition, it has several secondary effects that may have an overall impact on long-term survival, and that are of particular importance in patients surviving the primary b